Sialic acid–bearing paraproteins are implicated in heparin-like coagulopathy in patients with myeloma
- 22 October 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 136 (17) , 1988-1992
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal GammopathyJournal of Proteome Research, 2014
- Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell DisordersSeminars in Thrombosis and Hemostasis, 2011
- Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasiasBritish Journal of Haematology, 2009
- Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfateBlood Coagulation & Fibrinolysis, 2007
- Crystal Structure of Thrombin Bound to HeparinJournal of Biological Chemistry, 2005
- Report of three cases of circulating heparin‐like anticoagulantsAmerican Journal of Hematology, 2001
- The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor InteractionsJournal of Biological Chemistry, 1998
- Circulating heparin-like anticoagulants: Report of five consecutive cases and a reviewThe American Journal of Medicine, 1990
- Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding DisorderNew England Journal of Medicine, 1984
- Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.Journal of Clinical Investigation, 1980